Total Payments
$342,072
2024 Payments
$17,723
Companies
23
Transactions
458
Payment Breakdown by Category
Other$188,344 (55.1%)
Consulting$87,940 (25.7%)
Travel$60,721 (17.8%)
Food & Beverage$5,067 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $172,119 | 118 | 50.3% |
| Consulting Fee | $87,940 | 39 | 25.7% |
| Travel and Lodging | $60,721 | 197 | 17.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $9,375 | 3 | 2.7% |
| Honoraria | $6,850 | 3 | 2.0% |
| Food and Beverage | $5,067 | 98 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $90,263 | 119 | $0 (2019) |
| Merck Sharp & Dohme LLC | $68,777 | 79 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $41,072 | 98 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22,875 | 7 | $0 (2024) |
| PFIZER INC. | $20,987 | 33 | $0 (2024) |
| UROVANT SCIENCES INC | $18,023 | 33 | $0 (2022) |
| H. Lundbeck A S | $13,591 | 4 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $10,335 | 8 | $0 (2024) |
| Biogen, Inc. | $8,615 | 14 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $7,800 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,723 | 10 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($8,313) |
| 2023 | $18,905 | 20 | Teva Pharmaceuticals USA, Inc. ($7,562) |
| 2022 | $15,799 | 24 | UROVANT SCIENCES INC ($5,035) |
| 2021 | $21,420 | 27 | UROVANT SCIENCES INC ($12,988) |
| 2020 | $8,080 | 7 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($4,000) |
| 2019 | $50,418 | 79 | Sunovion Pharmaceuticals Inc. ($19,781) |
| 2018 | $70,659 | 77 | Janssen Pharmaceuticals, Inc ($27,768) |
| 2017 | $139,068 | 214 | Janssen Pharmaceuticals, Inc ($61,776) |
All Payment Transactions
458 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $7,837.50 | General |
| Category: Gastroenterology | ||||||
| 10/24/2024 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $490.00 | General |
| 10/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $475.00 | General |
| Category: Gastroenterology | ||||||
| 09/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Consulting Fee | Cash or cash equivalent | $4,214.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $115.91 | General |
| Category: PSYCHIATRY | ||||||
| 07/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: RESPIRATORY | ||||||
| 05/28/2024 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $425.00 | General |
| 04/03/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 04/03/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 04/03/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 12/20/2023 | UCB, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,400.00 | General |
| 12/14/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Consulting Fee | Cash or cash equivalent | $3,675.00 | General |
| Category: Central Nervous System | ||||||
| 11/18/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: Central Nervous System | ||||||
| 11/18/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Travel and Lodging | Cash or cash equivalent | $159.82 | General |
| Category: Central Nervous System | ||||||
| 11/18/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Travel and Lodging | Cash or cash equivalent | $46.70 | General |
| Category: Central Nervous System | ||||||
| 11/18/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
| Category: Central Nervous System | ||||||
| 11/02/2023 | PFIZER INC. | PAXLOVID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $350.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/02/2023 | PFIZER INC. | PAXLOVID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $350.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/13/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Travel and Lodging | In-kind items and services | $867.88 | General |
| Category: Urology | ||||||
| 09/13/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Travel and Lodging | In-kind items and services | $331.99 | General |
| Category: Urology | ||||||
| 03/30/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Consulting Fee | Cash or cash equivalent | $987.50 | General |
| Category: Urology | ||||||
| 03/30/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Travel and Lodging | Cash or cash equivalent | $945.83 | General |
| Category: Urology | ||||||
| 03/30/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Consulting Fee | Cash or cash equivalent | $790.00 | General |
| Category: Urology | ||||||
| 03/30/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Travel and Lodging | Cash or cash equivalent | $63.30 | General |
| Category: Urology | ||||||
| 03/30/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Travel and Lodging | Cash or cash equivalent | $26.46 | General |
| Category: Urology | ||||||
About Dr. Richard Stefanacci, DO
Dr. Richard Stefanacci, DO is a Geriatric Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689748600.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Stefanacci, DO has received a total of $342,072 in payments from pharmaceutical and medical device companies, with $17,723 received in 2024. These payments were reported across 458 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($172,119).
Ad
Practice Information
- Specialty Geriatric Medicine
- Location Philadelphia, PA
- Active Since 11/20/2006
- Last Updated 01/25/2022
- Taxonomy Code 207RG0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689748600
Products in Payments
- XARELTO (Drug) $90,263
- LONHALA MAGNAIR (Drug) $22,410
- GEMTESA (Drug) $22,067
- XIFAXAN (Drug) $20,875
- BROVANA (Drug) $11,595
- PREVNAR - 13 (Biological) $11,451
- Austedo XR (Drug) $7,562
- UTIBRON (Drug) $7,068
- REXULTI (Drug) $5,830
- Dayvigo (Drug) $2,925
- BRAHMS PCT KRYPTOR (Device) $2,500
- TOUJEO (Biological) $2,284
- RELISTOR (Drug) $2,000
- SOLIQUA 100/33 (Biological) $1,496
- PAXLOVID (Drug) $1,400
- Procalcitonin (Device) $1,200
- Xhance (Drug) $1,027
- MYALEPT (Drug) $971.89
- NUPLAZID (Drug) $360.16
- LINZESS (Drug) $124.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in Philadelphia
Dr. Michele Zawora, M.d, M.D
Geriatric Medicine — Payments: $21,383
Geriatric Medicine $21,383
Jason Karlawish, Md, MD
Geriatric Medicine — Payments: $17,422
Geriatric Medicine $17,422
Shikha Rathi, Mbbs, Md, MBBS, MD
Geriatric Medicine — Payments: $14,801
Geriatric Medicine $14,801
Dr. Ellen Zagrebelsky, Md, MD
Geriatric Medicine — Payments: $14,753
Geriatric Medicine $14,753
Dr. Anastassia Amaro, Md, MD
Geriatric Medicine — Payments: $13,913
Geriatric Medicine $13,913
Vladimir Zagrebelsky, M.d, M.D
Geriatric Medicine — Payments: $12,178
Geriatric Medicine $12,178